Ecomectin 18.7 mg/g Oral Paste for Horses

Country: Bretland

Tungumál: enska

Heimild: VMD (Veterinary Medicines Directorate)

Virkt innihaldsefni:

Ivermectin

Fáanlegur frá:

Eco Animal Health Ltd

ATC númer:

QP54AA01

INN (Alþjóðlegt nafn):

Ivermectin

Lyfjaform:

Oral paste

Gerð lyfseðils:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Meðferðarhópur:

Horses

Lækningarsvæði:

Endectocide

Leyfisstaða:

Authorized

Leyfisdagur:

2013-07-18

Vara einkenni

Revised: June 2023
AN: 00320/2023
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Ecomectin 18.7 mg/g Oral Paste for Horses
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains:
ACTIVE SUBSTANCE:
Ivermectin
18.7 mg
EXCIPIENT(S):
Titanium dioxide (E171) 20 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral Paste
A white homogeneous paste
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of nematode or arthropod infection due to:
Large strongyles:
_Strongylus vulgaris_ (adults and L
4
stage larvae [arterial])
_Strongylus edentatus_ (adults and L
4
stage larvae [tissue])
_Strongylus equinus_ (adults)
Small strongyles (including benzimidazole resistant strains):
_Cyathostomum _spp_ _(adults and luminal L
4
stage larvae)
_Cylicocyclus _spp. (adults and luminal L
4
stage larvae)
_Cylicodontophorus _spp. (adults and luminal L
4
stage larvae)
_Cylicostephanus _spp. (adults and luminal L
4
stage larvae)
_Gyalocephalus _spp. (adults and luminal L
4
stage larvae)
Ascarids:
_Parascaris equorum_ (luminal L
5
larvae and adults)
Pinworms:
_Oxyuris equi_ (L
4
stage larvae and adults)
Revised: June 2023
AN: 00320/2023
Page 2 of 6
Neck threadworms:
_Onchocerca _spp (microfilariae)
Stomach bots:
_Gasterophilus _spp (oral and gastric stages)
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the
excipients.
Do not use in dogs or cats as severe adverse reactions may occur.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Some horses with heavy infections of _Onchocerca_ spp. microfilariae
have
experienced oedema and pruritus following treatment, such reactions
are assumed to
be the result of death of large numbers of microfilariae. These signs
resolve within a
few days but symptomatic treatment may be advisable.
Care should be taken to avoid the following practices because they
increase the risk
of development of resistance and could ultimately res